BIO-RAD LABORATORIES, INC. - 10 Feb 2025 SCHEDULE 13G/A Report for Oncocyte Corporation Common Shares, No Par Value (OCX)

Filing Manager
BIO-RAD LABORATORIES, INC.
Reporting Manager
BIO-RAD LABORATORIES, INC
Security
Oncocyte Corporation Common Shares, No Par Value
Symbol
OCX
Shares outstanding
28,495,649 shares
Disclosed Ownership
2,764,078 shares
Ownership
9.7%
Form type
SCHEDULE 13G/A
Filing time
04 Mar 2025, 19:06:30 UTC
Date of event
10 Feb 2025
SEC
View on sec.gov

Sponsored

Quoteable Key Fact

"BIO-RAD LABORATORIES, INC. disclosed 9.7% ownership in Oncocyte Corporation Common Shares, No Par Value (OCX) on 10 Feb 2025."

Quick Takeaways

  • BIO-RAD LABORATORIES, INC. filed SCHEDULE 13G/A for Oncocyte Corporation Common Shares, No Par Value (OCX).
  • Disclosed ownership: 9.7%.
  • Date of event: 10 Feb 2025.

What Changed

  • No earlier schedule filing is available for direct comparison.
  • Current filing was accepted on 04 Mar 2025, 19:06.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Official SEC Source

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (1)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
BIO-RAD LABORATORIES, INC 9.7% 2,764,078 2,764,078 0 /s/ Courtney C. Enloe Courtney C. Enloe/Executive Vice President, General Counsel and Secretary

Sponsored